“Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study”, J of Skin, vol. 2, no. S1, p. S53, Feb. 2018, doi: 10.25251/skin.2.supp.53.